Investors Still Waiting For A Pull Back In Zhende Medical Co., Ltd. (SHSE:603301)

With a price-to-earnings (or "P/E") ratio of 43.5x Zhende Medical Co., Ltd. (SHSE:603301) may be sending bearish signals at the moment, given that almost half of all companies in China have P/E ratios

Simply Wall StApr 28 20:55 ET

Zhende Medical (603301.SH) announced first-quarter results, net profit of 73.3976 million yuan, a year-on-year decrease of 49.89%

Zhende Medical (603301.SH) released its report for the first quarter of 2024. The company's revenue was 964 million yuan...

Zhitong FinanceApr 26 06:16 ET

Zhende Medical (603301.SH): The ban on 39.2465 million restricted shares was lifted on March 26

Gelonghui March 20 丨 Zhende Medical (603301.SH) announced that the total number of shares in circulation in the company's current stock listing was 39.2465 million shares. The stock listing and circulation date is March 26, 2024.

Gelonghui FinanceMar 20 05:24 ET

Investors Could Be Concerned With Zhende Medical's (SHSE:603301) Returns On Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Amongst other things, we'll want to see two things; firstly, a growing return on

Simply Wall StMar 13 21:03 ET

Some directors and supervisors of Zhende Medical (603301.SH) completed a total reduction of 65,800 shares

Zhende Medical (603301.SH) announcement, Xu Dasheng, director and deputy general manager of the company, Zhang Xiantao, chairman of the supervisory board...

Zhitong FinanceJan 24 03:27 ET

Zhende Medical Co., Ltd. (SHSE:603301) Has A ROE Of 11%

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business.

Simply Wall StJan 19 00:08 ET